During the past 2 decades, results of both basic science and clinical studies have changed
the physicians' views about adipocyte pathophysiology. Since leptin was discovered in …

Cardiovascular calcification in patients with end-stage renal disease: A century-old
phenomenon. The mortality risk from cardiovascular disease is increased in patients with …

Background. End-stage renal disease is often associated with altered bone metabolism.
Methods. In order to investigate the determinant factors of bone mineral density (BMD) and …

Summary Background and Objective High levels of some adipocytokines have been
reported in patients with chronic renal failure, but little information is available on …

Metabolic syndrome (MS) and obesity participate in the pathogenesis of kidney disease. We
explored the impact of MS and post‐transplant weight gain on graft survival. Two hundred …

Inflammation is one of the well-recognized nontraditional risk factors that contributes to the
excessive cardiovascular mortality in peritoneal dialysis (PD) patients. Serum C-reactive …

Although the prevalence of aluminium‐related bone diseases has declined, osteomalacia
still persists at a low prevalence. The redistribution of bone disease prevalence corresponds …

Objective: Leptin, secreted from adipose tissue, regulates food intake, energy expenditure,
and immune function. It is unknown whether leptin predicts mortality in patients with chronic …

Peritoneal dialysis (PD) is a form of renal replacement therapy used in patients with end
stage renal disease (ESRD). It is based on using the peritoneum as a semipermeable …

Background. Ghrelin has been characterized as a relevant physiologic regulator of appetite
and body weight in humans. However, the potential relationships between ghrelin levels …